According to company’s press statement, the approval has been granted to market a generic equivalent of Xarelto Tablets, 2.5 mg, 10 mg, 15 mg, and 20 mg, of Janssen Pharmaceuticals, Inc. This ...

The company maintained that it can “largely compensate” for the Xarelto declines, which this quarter added up to a 23.8% year-over-year dip to 802 million euros ($851 million), pharma group ...